tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PASG Stock Latest News

PASG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsPASG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8h ago
PASG
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
PremiumMarket News
3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
4d ago
UPB
BNTX
Passage Bio’s Growth Potential Highlighted by Clinical Progress and Regulatory Alignment
PremiumRatings
Passage Bio’s Growth Potential Highlighted by Clinical Progress and Regulatory Alignment
5d ago
PASG
Passage Bio Reports Q3 Financial Results and Updates
PremiumCompany Announcements
Passage Bio Reports Q3 Financial Results and Updates
6d ago
8K
PASG
Passage Bio reports Q3 EPS ($2.44), consensus ($2.97)
PremiumThe Fly
Passage Bio reports Q3 EPS ($2.44), consensus ($2.97)
6d ago
PASG
Passage Bio’s PBFT02 Study: A Promising Step in Gene Therapy for Dementia
PremiumCompany AnnouncementsPassage Bio’s PBFT02 Study: A Promising Step in Gene Therapy for Dementia
20d ago
PASG
Optimistic Outlook for Passage Bio’s PBFT02: Promising Data and Potential FDA Support
Premium
Ratings
Optimistic Outlook for Passage Bio’s PBFT02: Promising Data and Potential FDA Support
25d ago
PASG
Promising Developments and Strong Financial Outlook Reinforce Buy Rating for Passage Bio
Premium
Ratings
Promising Developments and Strong Financial Outlook Reinforce Buy Rating for Passage Bio
3M ago
PASG
Passage Bio price target lowered to $67 from $260 at Canaccord
PremiumThe Fly
Passage Bio price target lowered to $67 from $260 at Canaccord
3M ago
PASG
Passage Bio Reports Q2 2025 Progress and Financials
PremiumCompany Announcements
Passage Bio Reports Q2 2025 Progress and Financials
3M ago
PASG
Passage Bio Reports Promising Q2 2025 Financial Results
PremiumCompany Announcements
Passage Bio Reports Promising Q2 2025 Financial Results
3M ago
8K
PASG
Passage Bio reports Q2 EPS ($2.96) vs ($5.09) last year
PremiumThe Fly
Passage Bio reports Q2 EPS ($2.96) vs ($5.09) last year
3M ago
PASG
Passage Bio expects cash to fund operations into Q1 of 2027
PremiumThe FlyPassage Bio expects cash to fund operations into Q1 of 2027
3M ago
PASG
Passage Bio Regains Nasdaq Compliance with Stock Price
Premium
Company Announcements
Passage Bio Regains Nasdaq Compliance with Stock Price
4M ago
8K
PASG
Passage Bio Announces Reverse Stock Split Effective July 14
Premium
Company Announcements
Passage Bio Announces Reverse Stock Split Effective July 14
4M ago
8K
PASG
Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested
PremiumMarket News
Upcoming Stock Splits This Week (July 14 to July 18) – Stay Invested
4M ago
GORV
HTOO
Passage Bio trading halted, news pending
PremiumThe Fly
Passage Bio trading halted, news pending
4M ago
PASG
Passage Bio announces 1-for-20 reverse stock split
PremiumThe Fly
Passage Bio announces 1-for-20 reverse stock split
4M ago
PASG
Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns
PremiumRatings
Optimistic Buy Rating for Passage Bio’s PBFT02: Promising Efficacy and Managed Safety Concerns
5M ago
PASG
Passage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating
PremiumRatingsPassage Bio’s Promising Clinical Trial Results and Strategic Adjustments Justify Buy Rating
5M ago
PASG
Passage Bio Releases Promising Interim Data for PBFT02
Premium
Company Announcements
Passage Bio Releases Promising Interim Data for PBFT02
5M ago
8K
PASG
Passage Bio Releases Promising Interim Data for PBFT02
Premium
Company Announcements
Passage Bio Releases Promising Interim Data for PBFT02
5M ago
8K
PASG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >